Categories
Health

How U.S. Epidemiologists Are Returning (Fastidiously!) to On a regular basis Life

Other said masks were required in outdoor situations where the distance could not be maintained, e.g. B. when picnicking or hiking. A quarter said masks were always necessary back then.

“Remember to always ensure two out of three: masks, outdoor distancing, especially for those who have not been vaccinated,” said Eyal Oren, an epidemiologist at San Diego State University.

During outdoor activities with large crowds where it is difficult to keep your distance, such as at a concert or protest, the epidemiologists almost all agreed that masks are still necessary regardless of vaccination status. Some suggested that we continue to avoid such events if possible. “There will almost certainly be vaccinated and unvaccinated people who mingle in an event like this,” said Steve Ostroff, an epidemiologist with a private practice.

The endless decisions about how to behave in the pandemic remain complicated. However, the risk calculations are starting to change. When it comes to pandemic decisions for people who have been vaccinated, it may ultimately be less about protecting society as a whole than about one’s own willingness to take risks.

“I think when all high-risk groups are vaccinated it is time to draw attention to the fact that everyone can decide for themselves what risks they are comfortable with,” said Anders Huitfeldt, epidemiologist at the University of Southern Denmark.

Some epidemiologists say this shift can happen once people are vaccinated: “Vaccination should open the floodgates to anything you could do before,” said Zachary Binney, an epidemiologist at Emory.

However, many said coronavirus precautions are important to protecting people at high risk and slowing the spread of the virus, even for people who have been vaccinated: “While I like to take personal risks, I wouldn’t tolerate risks that harm others said Kevin Andresen, who heads the Colorado Department of Public Health’s Covid Response Team. “Covid precautions protect everyone, not just me.”

Categories
Health

5 issues to know earlier than CDC panel votes on use in adolescents

A student receives her first Pfizer Biontech COVID vaccine at Ridley High School on May 3, 2021 as part of a clinic for students ages 16-18.

Pete Bannan | MediaNews Group | Daily times via Getty Images

A key CDC advisory body is due to vote on Wednesday on whether to recommend the use of Pfizer and BioNTech’s Covid-19 vaccine for children ages 12-15.

The widely awaited approval from the CDC’s Advisory Committee on Immunization Practices is the final step before US officials put their thumbs up on states to allow millions of teenagers to be vaccinated as early as Thursday.

Allowing teenagers to get the shots will accelerate the nation’s efforts to fight infection and return to some form of normalcy, say public health officials and infectious disease experts. It also allows states to vaccinate middle school students before summer camps start and school starts in the fall.

The Center for Disease Control and Prevention Panel meeting will take place two days after the Food and Drug Administration announced that it would approve Pfizer and BioNTech’s application to allow young teenagers to be vaccinated in an emergency. The vaccine is already approved for use in people aged 16 and over. It’s given in two doses three weeks apart in teenagers, the same regimen for 16 years and older, according to the FDA.

Here’s what to expect.

When do you vote?

According to a draft agenda, the meeting will take place from 11 a.m. to 5 p.m. The vote usually takes place towards the end.

Prior to voting, medical experts will evaluate clinical trial data from Pfizer and BioNTech and provide their views on the vaccine, including whether the benefits outweigh the risks for use in adolescents. The companies announced in late March that the vaccine was 100% effective in a clinical study involving more than 2,000 adolescents. The side effects were generally consistent with those seen in adults, they added.

What happens next?

Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, told reporters Monday he expected the first shots for young teenagers to be given as early as Thursday until the panel is approved and approved by the CDC director.

The distribution of vaccines will be different across the US, officials told reporters, as states have different regulations about who can give shots to younger age groups. The Biden government has announced plans to send vaccines directly to pediatrician offices and make doses available in other locations such as community centers.

Is the Vaccine Safe?

In a statement on Monday, incumbent FDA commissioner Dr. Janet Woodcock told parents that the agency “did a rigorous and thorough review of all available data” before clearing it for use on younger teenagers.

The FDA said the side effects in adolescents were consistent with those reported in clinical trial participants aged 16 and over. It was suggested that the vaccine should not be given to anyone who has had a history of severe allergic reactions, including anaphylaxis, a severe and potentially life-threatening allergic reaction.

The most commonly reported side effects, according to the FDA, were pain at the injection site, joints and muscles, fatigue, headache, chills, and fever. With the exception of pain at the injection site, more teens reported side effects after the second dose than after the first, the agency said. The side effects usually lasted one to three days.

When do younger children get access?

Studies are currently being carried out to test Covid vaccines in children under the age of 12. However, researchers believe these studies will take longer as they gradually examine younger age groups and experiment with lower doses after the vaccines are shown to be safe in older children.

FDA approval for children under the age of 12 could come in the second half of this year. In a presentation to coincide with the company’s earnings release on May 4th, Pfizer expects to file for approval of its toddler vaccine in September and toddler vaccine in November.

Moderna and Johnson & Johnson, whose vaccines are approved for people aged 18 and over, are also testing their recordings in younger age groups.

Do children need recordings for school and activities?

Possibly. For example, schools can legally require that students be vaccinated, according to Dorit Reiss, a law professor at UC Hastings College of Law.

Several colleges and universities have already stated that they need Covid vaccinations for students returning in the fall. It is possible that vaccinations are required to participate in after-school activities such as sports, arts, and other personal activities after school.

The federal government is unlikely to prescribe vaccines for children or other groups, public health experts say.

The CDC has previously said schools can safely reopen without vaccinating teachers or students. Biden’s government has announced it will invest $ 10 billion in Covid testing for schools to accelerate the return to one-to-one tuition across the country this fall.

Categories
Health

How Hospitals Can Assist Sufferers and the Planet

This article is part of our new series on the Future of Healthcare, which examines changes in the medical field.

As climate change evolves from a model of the future to a reality of the present, health systems across the country are facing tough questions. What should doctors do when forest fires, rising floods, or other natural disasters endanger their ability to care for patients? How can these institutions be resilient in the face of these disasters?

For Ramé Hemstreet, these are not abstract questions. Mr. Hemstreet is Vice President of Operations and Chief Sustainable Resources Officer for Kaiser Permanente, the California-based healthcare system. The state is already addressing the effects of climate change: During the Northern California wildfires in 2017 and 2019, Kaiser Permanente had to evacuate more than 100 patients from a Santa Rosa facility and find a way to care for the surrounding communities.

“The climate crisis is a human health crisis and we already live that in California,” said Hemstreet.

For the past decade, Mr. Hemstreet and his colleagues at the company have attempted to remove it from fossil fuels in an attempt to largely reduce the company’s contribution to climate change. However, it has also become clear that fossil fuel dependency is an obstacle to health care as the effects of climate change are increasingly part of the lived experience of many Americans.

Hospitals and health systems across the country are trying to answer the key question of how to care for patients when climate change threatens their ability to keep hospitals open. Many of the changes to improve resilience are not lean, technically advanced responses to crisis. Rather, they often represent sensible solutions: relocation of technical equipment from basements, in which floods could damage them, to higher floors; Arranging patient transfers before disasters; Improving energy efficiency; better air filters; and more backup systems and redundancies, just in case.

Since 2012, Boston Medical Center has reduced its energy use by nearly 40 percent and its greenhouse gas emissions from all energy sources by 90 percent while caring for more patients. Some of these savings can be attributed to a CHP power and heat plant that is 35 percent more efficient than the electricity supplier, who uses their energy needs separately. The hospital also bought enough solar power from a solar farm in North Carolina to cover all of its electricity.

BMC, the largest safety net hospital in New England serving the uninsured and underinsured community in the Boston area, has expanded its sustainability efforts beyond renewable electricity and heating, including a rooftop garden in the hospital that grows about 6,000 pounds of food a year for its pantry, stationary meals, and a hospital farmers’ market, and a biodigester that converts food waste into water.

Robert Biggio, an engineer who served in the Merchant Navy and is now senior vice president of facilities and support services for the hospital, learned resilience on the high seas. “People can’t reach you on a ship in the middle of the sea,” he said. “You don’t have a choice to be resilient.”

While it is often argued that sustainability and climate friendliness are too expensive, all system upgrades – including a cogeneration power plant and a cooling system with chilled water circuit instead of an expensive new tower – have saved BMC, a non-profit, significant amount of money.

“Waste reduction is more efficient and also improves resilience,” said Biggio. “They go hand in hand.”

Healthcare in the United States is responsible for an enormous amount of waste and a significant amount of greenhouse gas emissions. For every hospital bed, the American healthcare system produces about 30 pounds of waste every day. Overall, it accounts for around 10 percent of national greenhouse gas emissions.

Much of the waste comes from the shift towards disposable items for single use, apart from personal protective equipment, which is intended for single use only. Many hospitals use outside companies to clean and reprocess many of these items. Kaiser Permanente has committed to recycling, reusing or composting 100 percent of its non-hazardous waste by 2025.

In terms of greenhouse gas emissions, hospitals need to have backup power, usually provided by diesel generators. These run on fossil fuels and produce particulate matter known as PM 2.5, which contributes to asthma and other diseases. The air quality in hospitals, which have to test their generators regularly, is often poor.

A recent study found that colored people are more exposed to PM 2.5 from all sources compared to whites, and black Americans are most affected. As a result, these communities, which often do not have access to health care, are more likely to suffer the health consequences of this exposure. PM 2.5 is also responsible for 85,000 to 200,000 deaths per year in the US (according to the study), and long-term exposure to PM 2.5 correlates with hospitalization from Covid-19.

During the fire season and heatwaves, power may go out or utilities may turn off power to avoid sparks or system-wide blackouts. Both mean that hospitals have to be operated with their generators.

That hospitals are partially responsible for this pollution is an unacceptable irony, said Hemstreet.

Kaiser Permanente has been buying supply-scale renewable energy since 2015 and signed a contract in 2018 to purchase 180 megawatts of wind and solar energy and 110 megawatts of battery storage, which is currently under construction. Since 2010, the company has installed 50 megawatts of solar power in its systems and is installing a 9-megawatt-hour battery on the company’s campus in Ontario, California, which can be used to completely take most of the system off the grid.

In New York City, space constraints and less sunshine make ambitious installations difficult, but heatwaves present a similar challenge – the possibility of power outages and rolling outages that turn off air conditioning, with higher temperatures putting some older adults and the sick, in particular, at risk.

Like BMC, NYU Langone Health has built a cogeneration power plant for air conditioning powered by electricity, heat and steam. It’s 50 percent more efficient than electricity, according to Paul Schwabacher, senior vice president of facility management at NYU Langone.

Construction of the CHP plant was in progress prior to Hurricane Sandy in 2012, which was an eye-opening experience for the hospital system. During the storm, the flood reached the lower floors of the hospital, leaving 15 million gallons of contaminated water. More than 300 patients had to be evacuated from the hospital, including newborns in the intensive care unit who were carried down many flights of stairs by doctors and nurses.

The hospital was closed for two months after the storm. During that time, about 100 electricians were working on repairs, Schwabacher said. “We made lemonade,” he said, adding that they did repairs that would have been much more difficult with the hospital open, like cleaning all of the air ducts. They also rebuilt and expanded the emergency room, which was flooded during the storm.

Since then, the hospital has built a new building and restored older ones.

However, NYU Langone’s biggest effort towards resilience is new flood barriers around campus designed to protect against a storm surge seven feet above the level caused by Hurricane Sandy. The campus also has a 12-foot steel storm barrier on the loading ramp that can be raised hydraulically or manually. Valves on drains and sewers to prevent backflows outside the streets from being flooded; and steel gates and doors to contain the flood at critical points throughout the facility.

But building walls are not going to keep the effects of climate change away. This will be due to the reduction in greenhouse gas emissions across society, Schwabacher said.

“We are very, very confident that we will be protected, but we know that the next disaster will be different from the last.”

Categories
Health

‘CDC’s credibility is eroding’ amid conflicting masks steerage, ex-Obama official says

Dr. Kavita Patel criticizes the Centers for Disease Control and Prevention for not effectively updating their guidelines on Covid masks.

“I think the CDC’s credibility is waning as fast as the coronavirus cases,” Patel said on CNBC’s The News with Shepard Smith. “This is not good news because we need guidance in the workplace, we need school counseling.”

“There are men and women working outside on phone lines and power lines on the lines and they still wear masks because we make it up without these instructions,” Patel said. “This actually puts more of us at risk, so it is time to step up. These are the difficult parts of government-public health communication, but we desperately need someone to do this.”

Maine Republican Senator Susan Collins said her confidence in the agency was being undermined by conflicting CDC guidelines.

“I used to have the utmost respect for instructions from the CDC,” Collins said during a congressional hearing on Tuesday’s response to the pandemic. “I’ve always viewed the CDC as the gold standard. I don’t remember.”

The CDC did not immediately respond to CNBC’s request for comment.

Meanwhile, Alaska Republican Senator Lisa Murkowski has stated that federal mask requirements put fishermen’s work at risk.

“You’re on a boat. The winds are howling. Your mask is damp,” Murkowski said during the hearing. “Tell me how anyone thinks this is a sensible and sensible policy?”

Patel, who served in the Obama administration as political director for the Bureau of Intergovernmental Affairs and Public Engagement, echoed Murkowski’s concerns.

Categories
Health

Why Haven’t You Scheduled Your Covid Vaccine?

The rate at which people schedule appointments for their Covid-19 recordings is decreasing across the country. Are you one of the people who didn’t get the vaccine?

The Well Desk wants to hear from readers who are hesitant to get the shot – or have questions on behalf of someone who has concerns. What would you like more information about? Do you have any new questions about adolescents and vaccinations? Are you afraid of side effects or have you read conflicting information from different sources? Tell us what you want to know and we will find the answers.

How to submit a question: You can use the form below to send us your questions.

Categories
Health

UK well being startup Huma raises $130 million from traders

Dan Vahdat, CEO and Co-Founder of Huma.

you are

LONDON – The coronavirus pandemic has accelerated the shift towards digital health services and investors are keen to capitalize on the trend by making big stakes in space.

In the UK, London-based Huma announced Wednesday that it had raised $ 130 million in an investment round led by Bayer and Hitachi’s corporate venture arms. The cash injection was also supported by Samsung, Sony and Unilever mutual funds.

Founded in 2011 as Medopad, Humas Software enables clinicians to remotely monitor patients via a mobile app. It also uses a number of wearables and other devices to collect data on things like heart rate and oxygen saturation. The startup claims it is able to detect worsening patients’ health and decide whether or not to go to the hospital.

The company works with the UK National Health Service and governments in Germany and the United Arab Emirates. Dan Vahdat, CEO and co-founder of Huma, said the company offered its services to the NHS on a pro bono basis during the Covid-19 crisis.

“Last year we committed to caring for Covid patients free of charge,” Vahdat told CNBC in an interview. “We thought that was the right thing to do. We are very fortunate to have long-term, visionary investors to support us.”

Huma claims to have doubled the capacity or reach in some of the hospitals it works with in the UK by allowing clinicians to see twice as many patients as they normally would thanks to its “Hospital at Home” service. It is also said to have succeeded in reducing hospital admissions by a third.

According to results released by the National Health Service’s innovation arm, NHSX, doctors in London were able to support an average of 20 patients per hour with Huma, up from 12 patients per hour for employees who do not use the company’s technology. Using Huma also saved about 3 minutes less time that doctors would normally spend with patients.

In Germany, the company signed a contract with the government to buy pulse oximeters – which measure oxygen saturation – from Amazon. Huma insists that the work in support of governments’ pandemic responses is not for profit and that it has signed procurement agreements with health officials to help cover the costs.

Huma’s most recent round of funding gives the company the opportunity to raise an additional $ 70 million at a later date. Should it choose to do so, it would bring its valuation above $ 1 billion and give it “unicorn” status, said a person familiar with the matter, who preferred to remain anonymous as the information failed were released to CNBC.

This is the latest sign of investor confidence in the fast-growing digital healthcare industry. Last month, Swedish telemedicine startup Kry announced it had raised $ 300 million in a round to value the company at $ 2 billion.

A clinician uses the digital platform of the British healthcare start-up Huma.

you are

“The industry has already moved towards digital as a whole – the pandemic has accelerated it,” Vahdat said.

Huma, which has 125 employees according to LinkedIn, is still severely loss making. Vahdat says it is prioritizing growth for now.

“For us as a company, our vision is how we can most effectively influence the lives of people around the world so that everyone can live longer and fuller lives,” he said. “We believe that if we can achieve that vision, the money will take care of itself.”

Huma lost £ 11.6 million ($ 16.4 million) on 2019 sales of £ 5.4 million, according to a news from Companies House. However, sales grew more than 3,600% from the £ 146,000 reported in 2018. The group’s 2020 annual financial statements should be presented by September.

Although the company raised a sizable amount of money, Vahdat said the company still had most of the money in the bank from its last round in 2019. The company’s recent capital injection is aimed at building partnerships with companies like Bayer and expanding into markets like the US, Asia and the Middle East.

“We’re doing bigger projects with multinationals and governments,” said Vahdat. “Having a great track record helps us give them the confidence and potentially a better and more effective long-term partnership with some of our partners.”

Goldman Sachs acted as lead placement agent for Huma on the deal, while HSBC and Nomura acted as joint placement agents. Nomura is now also a shareholder in the company, said Huma.

Categories
Health

Covid-19 Vaccines: Novavax Stories Extra Delays

Novavax, one of the earliest players in the world’s vaccination race against Covid, delivered disheartening news Monday, saying its highly protective vaccine would not be approved in the US or UK until July and would not reach peak production by the end of the year.

The delays announced during a profit call with investors are the most recent setback for the little-known Maryland company that received up to $ 1.6 billion from the federal government last year and its product is in clinical trials has shown robust results. Despite these achievements, the company has struggled to show it can deliver on its promise to bring 2 billion doses to the world this year. Novavax has never launched a vaccine in its 34-year history.

Speaking on the conference call, the company’s President and Chief Executive Officer Stanley C. Erck said the regulatory and manufacturing hurdles causing the delay have now been resolved. “Almost all of the major challenges have been overcome and we can clearly see the light at the end of the tunnel,” he said.

Investors didn’t seem to agree: by Tuesday morning, the company’s stock had fallen to $ 133.86, down nearly 17 percent, although it rebounded a little later in the day.

“I don’t see much good for them right now,” said Rob Smith, general manager of Capital Alpha Partners, an investment research firm.

The company’s delay is unlikely to affect wealthy countries like the US, which are being flushed with vaccines from Moderna, Pfizer-BioNTech, and Johnson & Johnson.

It’s likely that this will have a significant impact on the rest of the world, however, as Novavax only signed a deal with Gavi, a public-private global vaccine partnership, last week to sell 1.1 billion doses of its shot at low and medium levels – to deliver. Income Countries. Novavax has other contracts with countries such as South Korea, Japan and Australia and has agreements with eight manufacturing facilities around the world.

In January, the company estimated it would reach its full production capacity of 150 million cans per month by the middle of this year. This forecast was later revised after a lack of supplies such as filters and the huge disposable bags used in vaccine production. On Monday, the company delayed its estimate again, anticipating production of 100 million cans per month by the end of the third quarter and production of 150 million cans per month by the fourth quarter.

One of its key manufacturing partners, the Serum Institute in India, has faced its own manufacturing and geopolitical challenges. A fire at the facility earlier this year reduced capacity, and in April Adar Poonawalla, director of Serum, urged the United States to restrict access to raw vaccine ingredients. And although Novavax’s contract with serum aims to serve the rest of the world through its agreement with Gavi, the Indian government has banned the export of vaccines from the country as it grapples with a deadly second wave of Covid-19.

“Serum is the backbone of global vaccine supplies,” said Andrea Taylor, associate director of the Duke Global Health Innovation Center, which pursues global vaccine businesses. “I think for countries in South and Southeast Asia in particular, as well as for countries in Africa, it is difficult to overestimate the impact this will have.”

Novavax has also thrown back regulatory hurdles. On Monday, company executives said a problem now resolved with an “assay” – a test that was required to confirm that their product could be consistently manufactured on a commercial scale at multiple factories – was gaining regulatory approvals around the world Delayed countries like the UK and the United States would not give approval until July. The company’s employees once said they were hoping to get approval for their vaccine in April.

The delay is particularly noticeable in the UK, where Novavax reported positive results from its clinical trial in January.

British officials convinced Novavax to set up a study there last year, partly because they promised rapid clinical development and regulatory approval. But time is running out: around two-thirds of UK adults have received an initial dose of a coronavirus vaccine, largely made by AstraZeneca, and each adult is expected to be offered one by the end of July.

Updated

May 11, 2021 at 4:32 p.m. ET

The role of the vaccine in the UK depends in part on how quickly Novavax can start distributing its vaccine. A UK factory that makes the vaccines has announced that they will be ready by the summer. The country recently turned away from AstraZeneca intake in younger people because of the risk of very rare blood clots, so Novavax may be an alternative for people under 40.

The country is also investigating the effects of giving a second dose of the Novavax vaccine to people who have already received a first dose of Pfizer or AstraZeneca.

In the US, the Novavax setback sheds new light on the massive deal with the US government. As recently as 2019, the company was on the verge of closing after another vaccine made a major trial and had to sell its manufacturing facility to raise money.

Last year, the Trump administration placed a big bet on the tiny company as part of its Operation Warp Speed ​​project, signing a $ 1.6 billion contract earlier this year to supply 110 million cans. In April, the total amount of the deal increased to $ 1.75 billion, according to Novavax. The company’s major study in the United States and Mexico is still ongoing, despite executives on Monday that they expected the results of that study “in a few weeks.”

Novavax officials said they now didn’t expect to deliver these doses by the end of this year or early 2022. A Novavax spokeswoman said there was no penalty for later delivery in her contract with the U.S. government.

Novavax’s spotty track record offers no confidence in the challenge of producing billions of cans, said Les Funtleyder, healthcare portfolio manager at E Squared Capital Management, which invests in domestic and emerging markets. “It seems they really weren’t prepared for a challenge of this magnitude,” he said.

Recent news about internal sales – such as the departure of Novavax’s chief financial officer last month, five months after he took office for personal reasons – doesn’t help, Funtleyder said. “It’s a bad look,” he said.

But even if there’s a challenging path to follow as a straggler, Novavax’s vaccine could fill important loopholes, some experts said. In the United States, it could be used as a booster shot to bolster dwindling immunity, or the Biden government could choose to donate the vaccine to other countries in need, as it does with the unused supply of AstraZeneca doses .

Novavax has announced that it will develop a new version of its vaccine to address the variant circulating in South Africa. And it was recently announced that it would be investigating the shot in children over the age of 12 to catch up with Moderna and Pfizer, who have already tested their products in that age group.

The vaccine can also be stored at normal refrigeration temperatures without the freezing temperatures required for Pfizer and Moderna vaccines.

“By the end of 2021, there will still be a great need for safe, effective vaccines that can travel well,” said Ms. Taylor of Duke University. “Novavax seems to fit that description.”

Dr. Saad B. Omer, director of the Yale Institute for Global Health, noted that countries with multiple vaccines available were able to switch to other options when concerns about Johnson & Johnson and AstraZeneca vaccines were raised due to blood clot association.

“It’s good to hedge our bets,” he said. “For example, if we want to avoid one body blow after another in low-income countries in many parts of the world that affects everyone, we have to vaccinate a large part of the world.”

Benjamin Mueller and Noah Weiland contributed to the reporting.

Categories
Health

Uber and Lyft will supply free rides to vaccination websites

A Lyft logo is featured on a Lyft driver car next to an Uber sticker in Pittsburgh.

Gene J. Puskar | AP

Uber and Lyft will offer free rides to vaccination sites through July 4th as part of a new partnership at the White House, the Biden government said on Tuesday.

“By helping Americans get to a vaccination site for free, Lyft and Uber are removing a potential barrier and bringing America closer to the president’s goal of reaching 70% of the US adult population with at least one shot by July 4th “White said House in a press release.

Both companies had already partnered with other companies to expand transport access to Covid vaccination sites. Tuesday’s announcement, however, builds on these commitments and introduces a formal government partnership.

The White House said the initiative would start within the next two weeks.

Uber didn’t immediately announce what the rides would look like on its app, but Lyft said a “ride code” will be available through its website or app by May 24th. Although the White House advertised the rides as free, Lyft said it would cover $ 15 one way each way. Lyft said in a statement that the amount should cover “most, if not all” of the fare based on previous trips to vaccination sites he has observed.

Users can get a code on Lyft’s website or app to get to a nearby vaccination site after providing some details. The codes can be used for standard rides as well as for scooters or bicycles offered through Lyft during standard pharmacy opening hours of 6 a.m. to 8 p.m.

“The vaccine is key to getting us all moving again and we are proud to be doing our part to move the country forward,” said Lyft co-founder and president John Zimmer in a statement. “We have always believed that transportation has the power to make people’s lives better, and this initiative makes that truer than ever. When more Americans get vaccinated, it will help the Lyft community of drivers and drivers, and we are the Biden -Administration grateful for prioritizing access. “

“Vaccines are our best hope to beat this pandemic, and soon everyone in America can take a free Uber to get their shot,” Uber CEO Dara Khosrowshahi said in a statement. “We are honored to deepen our previous global commitments and to work with the White House and Lyft to offer free rides to vaccination sites in the United States. This is a proud moment for me, for Uber, and for our country.”

Subscribe to CNBC on YouTube.

WATCH: Uber, Lyft Pledge Millions to Tackle Driver Shortage

Categories
Health

Want a Pandemic Reset? Strive This 10-Day Problem

While some people developed healthy new habits during the pandemic lockdown, if you’ve spent your pandemic days just getting through it, it’s not too late. The good news is that the end of the pandemic is likely a more propitious time for significant change than if you had the heightened fear of lockdowns.

“Covid-19 has been a terrible time for many of us,” said Laurie Santos, a psychology professor at Yale who teaches a popular online course called The Science of Well-Being. “There is a lot of evidence of what is known as post-traumatic growth – that we can come out stronger and with a little more meaning in our lives after negative events. I think we can all use this terrible time of the pandemic to achieve post-traumatic growth in our own lives. “

One of the biggest barriers to change has always been the fact that we tend to establish routines that are difficult to break. But the pandemic has destroyed many people’s routines and prepared us for a reset, said Dr. Santos.

“We’ve all changed our routines so much,” she said. “I think many of us realized during the pandemic that some of the things we did before Covid-19 weren’t the kind of things that made our lives flourish. I think many of us have realized that if we are to be happier, aspects of our work and family life, and even our relationships, may have to change. “

One reason new beginnings can be so effective is because people think about the passage of time in chapters or episodes rather than a continuum, said Dr. Milkman. As a result, we tend to look at the past in terms of unique periods, such as: For example, our high school years, college years, years we lived in a particular city or worked in a particular job. In the future, we will likely look back on the pandemic year as a similarly unique chapter in our lives.

“We have chapter breaks like life is a novel – that’s how we mark the time,” said Dr. Milkman. “This has an impact on the psychology of the new beginning, because these moments, which open a new chapter, give us the feeling of a new beginning. It is easier to attribute mistakes to the “old me”. You feel like you can do more now because we are in a new chapter. “

While the beginning of a new chapter is a good time to change, the pages will turn quickly. Now that we are getting out of the confines of pandemic life, social scientists say it is an ideal time to reflect on what you have learned over the past year. What new habits would you like to keep and what parts of your prepandemic life would you like to change?

Categories
Health

FDA clears use in children ages 12 to 15

The Food and Drug Administration on Monday approved Pfizer and BioNTech’s motion to allow their Covid-19 vaccine to be given to children ages 12-15 in an emergency so states can vaccinate middle school students before the fall.

The U.S. agency, which grants the use of the shot in teenagers, will also accelerate the country’s efforts to fight infection, say public health officials and infectious disease experts.

The two-dose vaccine is already approved for use in people aged 16 and over. The Centers for Disease Control and Prevention’s Vaccine Advisory Board scheduled a meeting on Wednesday to review the recordings for children. If approved by the CDC as expected, it could be distributed to teens as early as this week.

Acting FDA Commissioner Dr. Janet Woodcock said the decision “moves us closer to a return to a sense of normalcy and an end to the pandemic”. She assured parents that the agency “did a rigorous and thorough review of all available data” before approving it for teenage use.

The companies announced in late March that the vaccine was 100% effective in a clinical study involving more than 2,000 adolescents. They also said the vaccine produced a “robust” antibody response in the children that outperformed that in a previous study in older teenagers and young adults. The side effects were generally consistent with those seen in adults, they added.

Vaccinating children is seen as critical to ending the pandemic. The nation is unlikely to achieve herd immunity – if enough people in a given community have antibodies to a given disease – until children can be vaccinated, health officials and experts say.

According to the government, children make up around 20% of the total US population. According to experts, between 70% and 85% of the US population must be vaccinated against Covid to achieve herd immunity and some adults may refuse to get the shots. Although now more experts say herd immunity becomes less likely as variants spread.

The Chief Medical Officer of the White House, Dr. Anthony Fauci, said in April that the US could start vaccinating older children against Covid-19 from the fall, while elementary school-age children may get their shots early next year.

The vaccine is given in two doses three weeks apart, according to the FDA, with the same regimen according to the FDA for people aged 16 and over.

FDA approval for children under the age of 12 could come in the second half of this year. In a presentation to coincide with the company’s earnings release on May 4th, Pfizer expects to file for approval of its toddler vaccine in September and toddler vaccine in November. The filing process for full FDA approval for people aged 16 and over has already begun, the company announced on Friday.

In late March, Pfizer and BioNTech started a clinical trial testing their vaccine in healthy 6-month-old to 11-year-old children. Moderna and Johnson & Johnson, whose vaccines are approved for people aged 18 and over, are also testing their recordings in younger age groups.

The FDA’s announcement also comes in the context of President Joe Biden’s push to reopen schools for personal learning. Biden’s government has already announced that it will invest $ 10 billion in Covid testing for schools to accelerate returns to face-to-face courses across the country.

Vaccinating children can also give the green light to after-school activities such as sports, arts, and other personal activities.

While parents feel relieved that their children can be vaccinated, some health experts have questioned whether doses should be kept for children who are considered less at risk for serious illness while leaving vulnerable people around the world unprotected.

Dr. Craig Spencer, director of global health and emergency medicine at Columbia University Medical Center, said there need be no either-or choice between vaccinating children and distributing shots to the rest of the world. The US can do both, he said. But he’s frustrated that the US has stopped focusing on getting the rest of the world vaccinated.

“If I were to ask you whether a 12 year old with no medical problems or a 57 year old healthcare worker who cares for Covid patients every day should be vaccinated, the answer is very clear, right?” he said. “Why does this calculation change when it comes to a health worker from another country?”